Market Cap 136.38M
Revenue (ttm) 680,000.00
Net Income (ttm) -45.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,680.88%
Debt to Equity Ratio 0.00
Volume 617,800
Avg Vol 1,960,232
Day's Range N/A - N/A
Shares Out 66.53M
Stochastic %K 41%
Beta 1.28
Analysts Strong Sell
Price Target $10.50

Company Profile

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated ongoing or planned trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, and triple negative breast cancer...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 952 7570
Address:
11055 Flintkote Avenue, San Diego, United States
richapd
richapd Sep. 13 at 10:58 PM
$CRDF Would anyone be privy as to whether CRDF is presenting at GI ASCO early Jan 2026?
1 · Reply
Huber65
Huber65 Sep. 13 at 8:23 PM
$CRDF article on alpha seeks with biotechs possibly to be acquired by year end by pfe and others . Crdf not mentioned
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 6:31 PM
Enter: $CRDF OCT 17 2025 $2 CALLS Buy in Price: $0.10 - $0.15 Take Profit: $0.14 Stop Bleeding: $0.09 ROI Potential: 35% Exit Within: 17 Minutes https://moneygroup.us/alerts
0 · Reply
ForestFoxes
ForestFoxes Sep. 13 at 3:02 PM
$ANVS Post 1 of ... There is endless energy from supporters of Dr. Maccecchini on this channel who think that it's fine that she pitch her stock to patients and their families. I can't understand this. #CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #SEC The image attached is relevant as the document that Dr. Maccecchini got me to sign was dated and timed in the afternoon of May 13, 2024 at 3:05 PM. Any emails after this time point and date cannot be released unless I remove all material information thus the email would be so redacted it would be of little value to shareholders and any readers of this company. However, based on my interactions with the majority of investors on this channel it appears few, if any are interested in one of the most active and involved Retail investors on this channel, myself. Sadly, the emotional result of my efforts to share on this channel ... oof, it's too hard to put into words. The ending portion of a post on the $CRDF Stocktwits channel probably articulate my feelings better than I can: "Try living with that. And yes, I know it been a lot from this post. but I guess this is how I'm coping with it right now. Since this has started I haven't had a chance to process anything. I've been non-stop and a robot. This will be my last post because I know that stock twits is not what this is for"
2 · Reply
User123321
User123321 Sep. 12 at 3:30 PM
0 · Reply
PSDL75
PSDL75 Sep. 12 at 1:43 PM
$CRDF lovely action
1 · Reply
Deggie
Deggie Sep. 12 at 1:28 PM
$CRDF let's go!
0 · Reply
frogman2000
frogman2000 Sep. 11 at 11:21 PM
$CRDF big question is when will the market start to price in the phase 3 move? It will come way ahead of Q1/26. I expect to see revised spider plots once 6 month data for all patients gets reported
2 · Reply
BullRun4
BullRun4 Sep. 11 at 6:17 PM
$CRDF 🚨🚨🚨PATIENCE🚨🚨🚨
0 · Reply
sumerian
sumerian Sep. 11 at 6:13 PM
$CRDF Beat up pretty bad by this one over the last few weeks, Stopped out twice, then had to “chase price” back up three times to get onboard again, though I never usually do that. Should be worth well it long term though!
0 · Reply
Latest News on CRDF
Cardiff Oncology: Data Update Resolves Some Signals

Jul 30, 2025, 11:32 AM EDT - 6 weeks ago

Cardiff Oncology: Data Update Resolves Some Signals


Cardiff Oncology Names Roger Sidhu as Medical Chief

Jun 17, 2025, 4:39 PM EDT - 3 months ago

Cardiff Oncology Names Roger Sidhu as Medical Chief


Cardiff Oncology: Buying The First-Line Onvansertib Strategy

May 14, 2025, 9:05 AM EDT - 4 months ago

Cardiff Oncology: Buying The First-Line Onvansertib Strategy


Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 9:10 PM EST - 7 months ago

Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript


Cardiff Oncology to Present at Upcoming Investor Conferences

Feb 24, 2025, 4:05 PM EST - 7 months ago

Cardiff Oncology to Present at Upcoming Investor Conferences


Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:18 AM EDT - 1 year ago

Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript


richapd
richapd Sep. 13 at 10:58 PM
$CRDF Would anyone be privy as to whether CRDF is presenting at GI ASCO early Jan 2026?
1 · Reply
Huber65
Huber65 Sep. 13 at 8:23 PM
$CRDF article on alpha seeks with biotechs possibly to be acquired by year end by pfe and others . Crdf not mentioned
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 13 at 6:31 PM
Enter: $CRDF OCT 17 2025 $2 CALLS Buy in Price: $0.10 - $0.15 Take Profit: $0.14 Stop Bleeding: $0.09 ROI Potential: 35% Exit Within: 17 Minutes https://moneygroup.us/alerts
0 · Reply
ForestFoxes
ForestFoxes Sep. 13 at 3:02 PM
$ANVS Post 1 of ... There is endless energy from supporters of Dr. Maccecchini on this channel who think that it's fine that she pitch her stock to patients and their families. I can't understand this. #CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #SEC The image attached is relevant as the document that Dr. Maccecchini got me to sign was dated and timed in the afternoon of May 13, 2024 at 3:05 PM. Any emails after this time point and date cannot be released unless I remove all material information thus the email would be so redacted it would be of little value to shareholders and any readers of this company. However, based on my interactions with the majority of investors on this channel it appears few, if any are interested in one of the most active and involved Retail investors on this channel, myself. Sadly, the emotional result of my efforts to share on this channel ... oof, it's too hard to put into words. The ending portion of a post on the $CRDF Stocktwits channel probably articulate my feelings better than I can: "Try living with that. And yes, I know it been a lot from this post. but I guess this is how I'm coping with it right now. Since this has started I haven't had a chance to process anything. I've been non-stop and a robot. This will be my last post because I know that stock twits is not what this is for"
2 · Reply
User123321
User123321 Sep. 12 at 3:30 PM
0 · Reply
PSDL75
PSDL75 Sep. 12 at 1:43 PM
$CRDF lovely action
1 · Reply
Deggie
Deggie Sep. 12 at 1:28 PM
$CRDF let's go!
0 · Reply
frogman2000
frogman2000 Sep. 11 at 11:21 PM
$CRDF big question is when will the market start to price in the phase 3 move? It will come way ahead of Q1/26. I expect to see revised spider plots once 6 month data for all patients gets reported
2 · Reply
BullRun4
BullRun4 Sep. 11 at 6:17 PM
$CRDF 🚨🚨🚨PATIENCE🚨🚨🚨
0 · Reply
sumerian
sumerian Sep. 11 at 6:13 PM
$CRDF Beat up pretty bad by this one over the last few weeks, Stopped out twice, then had to “chase price” back up three times to get onboard again, though I never usually do that. Should be worth well it long term though!
0 · Reply
arcadiain
arcadiain Sep. 11 at 4:09 PM
$CRDF Surprisingly CRDF doing well this morning.
0 · Reply
PSDL75
PSDL75 Sep. 11 at 3:49 PM
$CRDF twice the bid had a large number fill...
1 · Reply
PSDL75
PSDL75 Sep. 11 at 2:55 PM
$CRDF welp....
0 · Reply
PSDL75
PSDL75 Sep. 11 at 2:52 PM
$CRDF This is a new development..stacking the bid/ask on this name.
0 · Reply
PSDL75
PSDL75 Sep. 11 at 1:19 PM
$CRDF PM load by shorts to be able to manipulate down under $2... sad
1 · Reply
arcadiain
arcadiain Sep. 10 at 11:52 PM
$CRDF https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=CRDF
0 · Reply
JanetBSmellin
JanetBSmellin Sep. 10 at 11:05 PM
$CRDF Fire Erlander, and then release good news. He would just find a way to fuck it all up.
0 · Reply
arcadiain
arcadiain Sep. 10 at 8:21 PM
$CRDF Looks like CRDF is drifting to a new low below $ 1.90. Would that be $ 1.77 before we see a bounce ?? I was expecting it to run up to $ 3.50 but in vain.
1 · Reply
PSDL75
PSDL75 Sep. 10 at 8:09 PM
$CRDF Seems to be getting more expensive as they bring it back down...needs to be more expensive to dissuade the shorting activity happening.
0 · Reply
PSDL75
PSDL75 Sep. 10 at 6:22 PM
$CRDF was that just a dead cat bounce to $2.25?
1 · Reply
Csab6362
Csab6362 Sep. 10 at 4:53 PM
$VSTM I added, not exactly at 9$, but still happy about it. Had to add some $CRDF too today…
0 · Reply
look2theblue
look2theblue Sep. 10 at 2:38 PM
$CRDF Traders expect the price to dip when Erlander opens his mouth, and so that's what it did yesterday. But really, he's just a figurehead at this point, $PFE is driving this bus.
0 · Reply